Cargando…

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Detalles Bibliográficos
Autores principales:	Sathish, Thirunavukkarasu, Tapp, Robyn J., Cooper, Mark E., Zimmet, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591867/ https://www.ncbi.nlm.nih.gov/pubmed/33129968 http://dx.doi.org/10.1016/j.diabet.2020.10.002

Ejemplares similares

Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2020)

Is There a Link Between Components of Health-Related Functioning and Incident Impaired Glucose Metabolism and Type 2 Diabetes?: The Australian Diabetes Obesity and Lifestyle (AusDiab) study
por: Tapp, Robyn J., et al.
Publicado: (2010)

Persistence of new-onset diabetes in the post-acute phase of COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2022)

Prevalence of normal weight obesity and its associated cardio-metabolic risk factors – Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP)
por: Kapoor, Nitin, et al.
Publicado: (2020)

Diabetes and its drivers: the largest epidemic in human history?
por: Zimmet, Paul Z.
Publicado: (2017)

Longitudinal Association of Glucose Metabolism With Retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study
por: Tapp, Robyn J., et al.
Publicado: (2008)

Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program
por: Kapoor, Nitin, et al.
Publicado: (2020)

Type 2 Diabetes: An Epidemic Requiring Global Attention and Urgent Action
por: Herman, William H., et al.
Publicado: (2012)

Participant recruitment into a community-based diabetes prevention trial in India: Learnings from the Kerala Diabetes Prevention Program
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2019)

Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2013)

A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program
por: Thankappan, Kavumpurathu R., et al.
Publicado: (2018)

New-Onset Diabetes in Covid-19
por: Rubino, Francesco, et al.
Publicado: (2020)

Commentary on the effects of gestational hypertension on new‐onset diabetes mellitus
por: Wang, Wen‐Chung, et al.
Publicado: (2013)

The long-term effects of Kerala Diabetes Prevention Program on diabetes incidence and cardiometabolic risk: a study protocol
por: Haregu, Tilahun, et al.
Publicado: (2023)

New-onset Diabetes after Renal Transplantation – A Clinical Insight
por: Sanyal, Debmalya
Publicado: (2019)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry
por: Papachristou, Stella, et al.
Publicado: (2020)

Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Risk of mortality in COVID-19 patients with newly diagnosed and pre-existing diabetes
por: Sathish, Thirunavukkarasu
Publicado: (2022)

Yoga- a potential solution for diabetes & metabolic syndrome
por: Naik, Dukhabandhu, et al.
Publicado: (2015)

Young-onset diabetes: An Indian perspective
por: Dutta, Deep, et al.
Publicado: (2019)

Allostasis and the origins of adult-onset diabetes
por: Leslie, R. David, et al.
Publicado: (2019)

The Discordance Between the Renal Histopathology and Clinical Presentation of Diabetic Nephropathy Calls for Novel Approaches for the Prediction and Monitoring of Kidney Failure in Diabetes
por: Østergaard, Jakob A., et al.
Publicado: (2021)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Predicting Adult-Onset Autoimmune Diabetes: Clarity From Complexity
por: Leslie, R. David
Publicado: (2010)

Newly diagnosed diabetes in patients with mild to moderate COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
por: Tufro, Alda
Publicado: (2013)

Newly diagnosed diabetes in COVID-19 patients
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Anti-inflammatory potential of Empagliflozin
por: Pirklbauer, Markus
Publicado: (2021)

Building a new bridge between metabolism, free radicals and longevity
por: Ralser, Markus, et al.
Publicado: (2009)

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?
por: Buse, John B., et al.
Publicado: (2018)

Glycated hemoglobin variability: A potential new risk marker for diabetes complications?
por: Jia, Weiping
Publicado: (2014)

Stimulating IL-13 Receptors on T cells: A New Pathway for Tolerance Induction in Diabetes?
por: Wong, F. Susan
Publicado: (2011)

Insulin Signaling Via Retinal Pericytes, New Insights and Potential Implications in Diabetic Retinopathy
por: Aldibbiat, Ali M
Publicado: (2021)

Causes of early-onset type 1 diabetes: toward data-driven environmental approaches
por: Bougnères, Pierre, et al.
Publicado: (2008)

Role of inflammatory biomarkers in diabetic peripheral neuropathy
por: Jin, Heung Yong, et al.
Publicado: (2018)

Diabetes Family History: A Metabolic Storm You Should Not Sit Out
por: Franks, Paul W.
Publicado: (2010)

Euglycemic diabetic ketoacidosis: a potential pitfall for the emergency physician
por: Jarvis, Paul Richard Edwin
Publicado: (2023)

Can Early Onset of Disease Be One of the Risk Factors for Low Bone Mineral Density in Patients with Inflammatory Bowel Disease?
por: Kwon, Kwang An, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9an8flc8316q3htshnihh98bad